Welcome to The Daily AI Briefing, your daily dose of AI news. I'm Marc, and here are today's headlines. Today, we're covering major developments from Mistral AI's latest multimodal model, Perplexity's new AI shopping features, groundbreaking research on ChatGPT's medical diagnosis capabilities, and several other exciting AI innovations in healthcare and security. Let's dive into our first story. Mistral AI, the French AI powerhouse, has just released Pixtral Large, their most ambitious project to date. This 124B parameter multimodal model is making waves by outperforming industry giants like Gemini 1.5 Pro and GPT-4 in math reasoning and document comprehension. With its impressive 128K context window, Pixtral Large can simultaneously process 30 high-resolution images or a 300-page book. Their Le Chat platform now includes web search, document analysis, and AI image generation, with a new Canvas feature for real-time content creation. Moving to e-commerce, Perplexity has launched an innovative AI shopping experience for US Pro users. This new system brings a fresh approach to online shopping, understanding complex queries and delivering unsponsored, AI-driven recommendations. The platform includes features like "Buy with Pro" offering free shipping and one-click purchases, plus an innovative "Snap to Shop" tool that lets users photograph real-world items to find them online. In healthcare news, a groundbreaking study from UVA Health System has revealed that ChatGPT-4 significantly outperforms human doctors in diagnostic accuracy. The AI achieved a remarkable 90% accuracy rate on complex medical cases, compared to 74% for doctors working without AI assistance. The study, involving 50 physicians across multiple hospitals, highlighted an interesting challenge: doctors often didn't fully utilize AI's capabilities and sometimes dismissed its suggestions when they conflicted with their initial diagnoses. On the medical technology front, Microsoft has introduced BiomedParse, a GPT-4-powered system for medical image analysis, while the NIH has launched TrialGPT, an AI algorithm that matches patients to clinical trials with impressive accuracy, cutting screening time in half. Finally, in an innovative approach to cybersecurity, UK mobile network O2 has deployed Daisy, an AI chatbot designed to combat phone scammers. This clever bot engages scammers in lengthy conversations about mundane topics like knitting and family, successfully keeping them occupied for up to 40 minutes and preventing them from targeting vulnerable individuals. That's all for today's AI Briefing. From breakthrough medical diagnostics to scammer-fighting chatbots, we're seeing AI reshape various sectors in fascinating ways. Join us tomorrow for more updates on the rapidly evolving world of artificial intelligence. I'm Marc, and thank you for listening.